Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies

Zoetis announced that the FDA has granted an Emergency Use Authorization (EUA) for Simparica Trio to treat New World screwworm infestations in dogs and puppies. The authorization addresses a specific threat where several states have issued orders requiring treatment for animal movement, expanding the utility of Zoetis' flagship all-in-one parasiticide.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.